Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
42 /100
MEDIUM RISK
Score updated Oct 13, 2026

SGMO — Sangamo Therapeutics, Inc. Dilution Risk Tracker

Track SGMO dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track SGMO — Get alerts when the score changes →

As of October 13, 2026, Sangamo Therapeutics, Inc. (SGMO) has a DilutionWatch DilutionScore of 42/100, rated MEDIUM dilution risk. Sangamo Therapeutics, Inc. has a market capitalization of $91.14M, 414.29M shares outstanding, 114 institutional holders tracked. Stored dilution-related fields include ATM program capacity of $131.20M.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
42
💰 Cash Runway
65
📊 Float Risk
2
⚠️ Warrant Exposure
40
🔄 Convertible Debt
40

Dilution Forecast

⛈️
Warning
High probability of dilution event
model est. 42%
🔄 Reverse Split model est. 65%
• 50-day avg $0.22 below $1 exchange minimum
• 9 months cash with weak price
💰 Capital Raise model 33%
• Under 12 months cash (9mo)
• Active ATM program with $131M remaining capacity
🔔 Track SGMO — Get forecast alerts →

Market Data

Market Cap$91.14M
Shares Outstanding414.29M
Float410.04M
Cash$121.97M
Debt$19.33M
Short InterestN/A

Source-Backed Evidence Depth

This public preview uses stored DilutionWatch fields and linked SEC/market records only. Missing values are not estimated.

FieldCurrent ValueBasis
DilutionScore42/100DilutionWatch score record
Shares Outstanding414.29MVerified float table or market cache
Public Float410.04MVerified float table or market cache
Market Cap$91.14MMarket data cache
Cash Runway9.1 monthsDilutionWatch score inputs
Shelf CapacityNone in current score inputsSEC-derived dilution fields
ATM Capacity$131.20MSEC-derived dilution fields
Outstanding WarrantsNone in current score inputsSEC-derived dilution fields

Recent source-backed SEC insight records available on this page: 7.

Recent SEC source mix: 4 5, XBRL 2.

The page does not infer future share issuance, financing probability, cash needs, management intent, or price impact when source fields are absent.

Institutional Holdings

QoQ: ↑ 92.1% shares (2026Q1 vs prior)
114 institutional holders · 122.97M shares
#1 ARMISTICE CAPITAL, LLC 40.40M shares
#2 VANGUARD CAPITAL MANAGEMENT LLC 25.41M shares
#3 TWO SIGMA INVESTMENTS, LP 6.27M shares
+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

No current FINRA short-interest record is available for this ticker.

Recent SEC Activity

xbrl XBRL CONVERTIBLE 2026-03-30
xbrl XBRL WARRANT 2025-11-06
4 INSIDER TRANSACTION 2026-04-23
4 INSIDER TRANSACTION 2026-04-23
4 INSIDER TRANSACTION 2026-04-03
Full SEC filing analysis available with free account →

Recent News

No recent news available for this ticker.

Factual SGMO Dilution Snapshot

Sangamo Therapeutics, Inc. (SGMO) has a DilutionScore of 42/100, rated Medium dilution risk. Score date: October 13, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

DilutionScore History — Last 90 Days

SGMO's DilutionScore is currently 42/100 (Medium risk), with 2 score changes tracked over 89 days. The score deteriorated from 45/100 (Medium risk).

Period Score Risk Level Duration
Aug 22 – Oct 13, 202642/100MEDIUM53 days
Aug 14 – Aug 21, 202645/100MEDIUM7 days
Jul 16 – Aug 13, 202642/100MEDIUM29 days

Score recalculated daily from SEC filings and market data. Sign up free for real-time score change alerts.

Share Dilution History

SGMO shares outstanding have increased 11.5% from 371.68M (Mar 2026) to 414.27M (Apr 2026). Each increase represents potential dilution to existing shareholders.

Date Shares Outstanding Public Float Change
Apr 07, 2026414.27M406.77M▲ 0.21%
Mar 09, 2026371.68M329.70M▼ 0.04%

Share counts sourced from verified regulatory filings. Increases indicate dilution events.

Track SGMO Dilution Risk in Real-Time
DilutionWatch monitors SEC filings 24/7 and alerts you the moment SGMO files a shelf registration, ATM offering, warrant notice, or convertible note. Free tier available — no credit card required.
Start Tracking SGMO — Free
Email alert within minutes of any SEC filing Daily DilutionScore™ recalculation Score history & trend tracking Tracks 8,000+ tickers simultaneously

Related Stocks — MEDIUM Risk

Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,490+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for SGMO
SGMO FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.